Paper3759657
K-252a, a potent inhibitor of protein kinase C from microbial origin.
Kase H and 2 others. J Antibiot (Tokyo), 1986. Cited by 299 papers, by iCite.
Cite this record
ConductScience Library. K-252a, a potent inhibitor of protein kinase C from microbial origin. Papers, record 3759657. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3759657
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Carbazoles | Major topic |
| Protein Kinase C | Major topic |
| Actinomycetales | |
| Animals | |
| Bacteria | |
| Calmodulin | |
| Fermentation | |
| Indole Alkaloids | |
| Mice | |
| Phosphodiesterase Inhibitors |
Source PubMed
Cited by52
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 299 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42676594 | Differential effects of cannabidiol on inhibitory avoidance memory reconsolidation and consolidation are associated with distinct hippocampal proBDNF and BDNF signaling profiles. | Front Neurosci | 2026 | https://conductscience.org/library/papers/42676594 | PubMed |
| 42566421 | Delayed growth of SK-ES-1 Ewing sarcoma tumor xenografts is associated with reduced Trk and IGF1R pathway markers. | Oncotarget | 2026 | https://conductscience.org/library/papers/42566421 | PubMed |
| 41096950 | Staurosporine as an Antifungal Agent. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41096950 | PubMed |
| 40978808 | CAMKV Kinase Signaling Is a Novel Therapeutic Avenue with Prognostic Relevance in Neuroblastoma. | bioRxiv | 2024 | https://conductscience.org/library/papers/40978808 | PubMed |
| 38399426 | The Antitubercular Activities of Natural Products with Fused-Nitrogen-Containing Heterocycles. | Pharmaceuticals (Basel) | 2024 | https://conductscience.org/library/papers/38399426 | PubMed |
| 38099919 | Chemistry and biology of specialized metabolites produced by Actinomadura. | Nat Prod Rep | 2024 | https://conductscience.org/library/papers/38099919 | PubMed |
| 35923716 | FLT3 inhibitors for acute myeloid leukemia: successes, defeats, and emerging paradigms. | RSC Med Chem | 2022 | https://conductscience.org/library/papers/35923716 | PubMed |
| 35736177 | Genus Nocardiopsis: A Prolific Producer of Natural Products. | Mar Drugs | 2022 | https://conductscience.org/library/papers/35736177 | PubMed |
| 34774343 | A review of FLT3 inhibitors in acute myeloid leukemia. | Blood Rev | 2022 | https://conductscience.org/library/papers/34774343 | PubMed |
| 31118539 | Synthetic Applications and Methodological Developments of Donor-Acceptor Cyclopropanes and Related Compounds. | Isr J Chem | 2016 | https://conductscience.org/library/papers/31118539 | PubMed |
| 31026161 | Fixing the Unfixable: The Art of Optimizing Natural Products for Human Medicine. | J Med Chem | 2019 | https://conductscience.org/library/papers/31026161 | PubMed |
| 30134565 | New Cytotoxic Cyclic Peptide from the Marine Sponge-Associated Nocardiopsis sp. UR67. | Mar Drugs | 2018 | https://conductscience.org/library/papers/30134565 | PubMed |
| 30026697 | c-Jun N-Terminal Kinases (JNKs) in Myocardial and Cerebral Ischemia/Reperfusion Injury. | Front Pharmacol | 2018 | https://conductscience.org/library/papers/30026697 | PubMed |
| 29934602 | Staurosporine: new lease of life for parent compound of today's novel and highly successful anti-cancer drugs. | J Antibiot (Tokyo) | 2018 | https://conductscience.org/library/papers/29934602 | PubMed |
| 29781959 | Involvement of the VGF-derived peptide TLQP-62 in nerve injury-induced hypersensitivity and spinal neuroplasticity. | Pain | 2018 | https://conductscience.org/library/papers/29781959 | PubMed |
| 29710816 | Natural Product Potential of the Genus Nocardiopsis. | Mar Drugs | 2018 | https://conductscience.org/library/papers/29710816 | PubMed |
| 29690896 | Marine-derived protein kinase inhibitors for neuroinflammatory diseases. | Biomed Eng Online | 2018 | https://conductscience.org/library/papers/29690896 | PubMed |
| 29661832 | Kinase activity in the olfactory bulb is required for odor memory consolidation. | Learn Mem | 2018 | https://conductscience.org/library/papers/29661832 | PubMed |
| 28660044 | The total synthesis of K-252c (staurosporinone) via a sequential C-H functionalisation strategy. | Chem Sci | 2016 | https://conductscience.org/library/papers/28660044 | PubMed |
| 28305726 | Metamorphosis inHydractinia: Studies with activators and inhibitors aiming at protein kinase C and potassium channels. | Rouxs Arch Dev Biol | 1990 | https://conductscience.org/library/papers/28305726 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3759657
GET https://conductscience.org/api/papers/v1/3759657/cited_by?page=2